Status:
UNKNOWN
Plasma microRNA Levels and Some Cytokines Expression in Patients With ITP Primary Immune Thrombocytopenic Purpura (ITP)
Lead Sponsor:
Sohag University
Conditions:
Primary Immune Thrombocytopenia
Eligibility:
All Genders
18-90 years
Brief Summary
Immune thrombocytopenia (ITP) is an autoimmune disease characterized by low platelet counts with or without mucocutaneous bleeding (McMillan, 2007). Like the majority of autoimmune diseases, ITP is an...
Detailed Description
In recent years the critical role of miRNAs has been established in many diseases, including autoimmune disorders. Immune thrombocytopenic purpura (ITP) is a predominant autoimmune disease, in which a...
Eligibility Criteria
Inclusion
- ITP patients
Exclusion
- 1- Secondary causes of ITP as systemic lupus erythematosus (SLE), viral infections (HIV, hepatitis B or C infections) 2- Other underlying medical diseases that may cause thrombocytopenia as:
- malignancy
- megaloblastic anemia
- aplastic anemia
- lymphoproliferative disorders
- liver disease
- renal impairment
- pregnancy 3-Organomegally and/or lymphadenopathy. 4-Recent history of vaccination. 5-Recent evidence of bacterial infection.
Key Trial Info
Start Date :
May 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2023
Estimated Enrollment :
2 Patients enrolled
Trial Details
Trial ID
NCT05371743
Start Date
May 1 2022
End Date
September 1 2023
Last Update
April 12 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sohag University
Sohag, Egypt, 82733